Exosomes-mediated CRISPR/Cas delivery: A cutting-edge frontier in cancer gene therapy
Gene · 2025-04 · 944 · 149296
DOI: 10.1016/j.gene.2025.149296 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Gene, 2025-04. Verfasst von Bhavanisha Rithiga S und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Stem Cell Biology Laboratory, Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu Dis…. Hauptthemen laut MEDLINE: Exosomes, CRISPR-Cas Systems, Neoplasms, Genetic Therapy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 125 Literaturangaben.
Abstract (Originalsprache)
Cancer is considered the second most common disease globally. In the past few decades, many approaches have been proposed for cancer treatment. One among those is targeted therapy using CRISPR/Cas system which plays a significant role in translational research through gene editing. However, due to its inability to cope with specific targeting, off-target effects, and limited tumor penetration, it is very challenging to use this approach in cancer studies. To increase its efficacy, CRISPR components are engineered into the extracellular vesicles (EVs), especially exosomes (a subpopulation of EVs). Exosomes have a significant role in cellular communication. Exosomes-based CRISPR/Cas system transport for gene editing enhances specificity, reduces off-target effects, and improves the therapeutic potential. This review highlights the role of exosomes and the CRISPR/Cas system in cancer research, exosomes-based CRISPR delivery for cancer treatment, and its future orientation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer and Stem Cell Biology Laboratory, Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, TamilNadu 603203, India.
- Cancer and Stem Cell Biology Laboratory, Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, TamilNadu 603203, India. Electronic address: devia@srmist.edu.i…
Zitieren
APA
S, B. R., Dhar, R., & Devi, A. (2025). Exosomes-mediated CRISPR/Cas delivery: A cutting-edge frontier in cancer gene therapy. Gene, 944, 149296. https://doi.org/10.1016/j.gene.2025.149296
Vancouver
S BR, Dhar R, Devi A. Exosomes-mediated CRISPR/Cas delivery: A cutting-edge frontier in cancer gene therapy. Gene. 2025;944:149296. doi:10.1016/j.gene.2025.149296
BibTeX
@article{S2025,
author = {S, Bhavanisha Rithiga and Dhar, Rajib and Devi, Arikketh},
title = {Exosomes-mediated CRISPR/Cas delivery: A cutting-edge frontier in cancer gene therapy},
journal = {Gene},
year = {2025},
volume = {944},
pages = {149296},
doi = {10.1016/j.gene.2025.149296}
}
EUVIMED